PapersPMID:35728870
L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression.
What moved
1 findingHow to read these marks →- Inhibits CD274
insufficient
“In syngeneic mouse tumor models, treatment with 100 mg/kg L-5-HTP (intraperitoneal) inhibited PD-L1 expression and exhibited antitumor effect.”
- Study
- animal · not in humans
- Dose studied
- 100 mg/kg intraperitoneal
- Population
- syngeneic mouse tumor models
Study record
- Design
- animal study, in vivo / mechanistic study
- Species
- mixed
- Population
- cell-based flow-cytometry screen of 200 metabolic molecules and syngeneic mouse tumor models
- Participants
- not reported
- Comparator
- an active treatment
- Duration
- not reported
- Endpoints measured
- 3
5-hydroxy-L-tryptophan